← Open Payments lookup

REBECCA LEISTICO: Open Payments

NPI 1114695327 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$926 in 39 payments from 10 companies in 2025. Trend: 2023 $872 · 2024 $1,424 · 2025 $926

Food & beverage: $847Education: $79
CompanyPaymentsAmount
Janssen Biotech, Inc.16$417
Ardelyx, Inc.3$143
ABBVIE INC.9$139
Madrigal Pharmaceuticals5$94
Gilead Sciences, Inc.1$32
Lilly USA, LLC1$24
Amgen Inc.1$23
Takeda Pharmaceuticals U.S.A., Inc.1$23
Celltrion USA Inc.1$15
GENZYME CORPORATION1$15

Products named: TREMFYA, IBSRELA, REZDIFFRA, RINVOQ, SKYRIZI, CREON, OMVOH, UPLIZNA.

Industry payments across NE — which companies pay providers there.